Already a Bloomberg.com user?
Sign in with the same account.
Nov. 2 (Bloomberg) -- MorphoSys AG and Shionogi & Co. Ltd. agreed to extend their research partnership by three years, giving the German biotechnology company undisclosed annual user fees. Further financial details weren’t revealed.
Link to Statement:{NSN LU0ST93PWT1E <GO>}
To contact the editor responsible for this story: Angela Cullen at acullen8@bloomberg.net